NCT05756049
Enrolling By Invitation
Not Applicable
Procalcitonin Protocol Use to Guide Antibiotic Therapy Duration in the Intensive Care Unit
ConditionsComparing Antibiotic Duration of Therapy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Comparing Antibiotic Duration of Therapy
- Sponsor
- Methodist Health System
- Enrollment
- 208
- Locations
- 1
- Primary Endpoint
- Total days of antibiotic therapy
- Status
- Enrolling By Invitation
- Last Updated
- 2 years ago
Overview
Brief Summary
To compare and contrast antibiotic use and its effects on patient outcomes before and after the implementation of a PCT protocol in the ICU at Methodist Richardson Medical Center (MRMC).
Detailed Description
Based on previous clinical trials, current literature supports the use of PCT levels in combination with clinical assessments to help determine optimal antibiotic therapy. On May 30, 2022, MRMC launched a PCT protocol in the ICU that allows clinical pharmacy specialists to order PCT levels in certain bacterial infections. In order to determine the effects of the protocol, a retrospective quasi-experimental review will be conducted
Investigators
Eligibility Criteria
Inclusion Criteria
- •● Patients aged 18 years or older
- •Patients being monitored on the PCT protocol
- •ICU location status for at least part of the admission
- •Received antibiotics in the ICU for a diagnosis of:
- •Community-acquired pneumonia
- •Hospital-acquired pneumonia
- •Ventilator-associated pneumonia
- •Sepsis and/or septic shock
- •Uncomplicated bacteremia with known source
- •Chronic obstructive pulmonary disorder exacerbation
Exclusion Criteria
- •Received antibiotics in the ICU for a diagnosis of:
- •Uncomplicated skin and soft tissue infections
- •Bacterial infections that require prolonged antibiotic therapy (e.g., osteomyelitis, endocarditis, tuberculosis, etc.)
- •Intra-abdominal infection
- •Urinary tract infection
- •Bacterial meningitis
- •Estimated Glomerular Filtration Rate \<15 mL/min
- •Requiring renal replacement therapy
- •Status post cardiac arrest/target temperature management
Outcomes
Primary Outcomes
Total days of antibiotic therapy
Time Frame: 6 months
Actual antibiotic days and predicted antibiotic days (i.e., SAAR)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Procalcitonin Guided Antibiotic Therapy and Hospitalisation in Patients With Lower Respiratory Tract Infections: The "ProHOSP" StudyLower Respiratory Tract InfectionPneumoniaBronchitisNCT00350987University Hospital, Basel, Switzerland1,002
Completed
Not Applicable
sefulness of a novel biomarker procalcitonin to guide antibiotic therapy in children with chest infectionsISRCTN17057980niversity Children's Hospital Basel (Switzerland)337
Unknown
Not Applicable
Procalcitonin-guided Antibiotic Therapy During Severe Exacerbation of COPDAcute Exacerbation CopdNCT03440060University Hospital, Mahdia100
Completed
Not Applicable
Procalcitonin as a Marker for the Length of Antibiotic Treatment in Peritonitis and Intra-abdominal InfectionsSecondary or Tertiary PeritonitisNCT01155739University of Lausanne Hospitals162
Completed
Not Applicable
PROcalcitonin Impact on Antibiotic Reduction, adverSe Events and AVoidable healthcarE Costs (ProSAVE): A RCTPneumonia, BacterialNCT04158804Massachusetts General Hospital700